CPHI Milan 2026

EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles

    During recent decades biopharmaceuticals such as monoclonal antibodies peptides or nucleic acids have gained impressive attention as revolutionary therapeutics and vaccine strategies attempting to fulfil the high expectations of resolving serious health conditions Regarding nucleic acids DNA and mRNAbased technologies have been established as extremely promising approaches in therapy and preventio...

    Exploring the Benefits of Sustainable Clinical Trials

    The landscape of clinical trials is evolving with a growing recognition that research endeavors should extend beyond scientific excellence to encompass broader societal environmental and economic considerations

    Key Stages in Pharmaceutical Formulation Development: A Complete Guide

    One of the most significant operations in the field of drug study is pharmaceutical formulation development to ensure that the medications are distributed to the patients without harm and in the most appropriate manner This is a science that involves the transformation of an active pharmaceutical ingredient API into a solid efficient and convenient dosage form To researchers manufacturers and regu...

    10 Essential Factors for Selecting a Pharma Publisher in Europe

    European pharmaceutical industry is one of the most progressive professional and productive industries in the world As it is understood researchers aspiring to publish novel papers are interested in credible pharma publishers Selecting appropriate publisher increases the visibility of your work and contributes to societal benefit but choosing wrong publisher decreases the value of your work This g...

    Digital Twins: The Future Blueprint for Pharmaceutical Production

    Digital Twins have revolutionized the pharmaceutical industry by providing virtual replicas of physical assets and processes This innovative technology offers a comprehensive view of manufacturing

    Lessons from Technology Transfer in Global Drug Product Development: From Knowledge Transfer to Commercial Success

    Technology transfer is the critical bridge between pharmaceutical development and commercial manufacturing transforming scientific innovation into medicines that can be reliably produced at scale Successful technology transfer extends far beyond the transfer of manufacturing processes and documentation

TOP ARTICLES

  • 1

    Exploring the Benefits of Sustainable Clinical Trials

    Debi Jones

    Sustainable clinical trials signify a transformative shift in research, integrating scientific rigor with environmental responsibility, resource efficiency, and community engagement. This paradigm enh...

press releases Read more...

Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value

Jupiter Neurosciences Inc NASDAQ JUNS a clinicalstage biopharmaceutical company developing investigational therapies for neurodegenerative diseases today announced that the first patient has been dosed

First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)

Telix Pharmaceuticals Limited today announces that the first patients in the United States US have been dosed with Pixclara floretyrosine F or FFET its FDAapproved amino acid positron emission

VTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)

VTv Therapeutics Inc Nasdaq VTVT a latestage biopharmaceutical company advancing cadisegliatin a novel oral investigational therapy for type diabetes TD today announced that the Company has completed

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

Crescent Biopharma Inc Crescent or the Company Nasdaq CBIO a clinicalstage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients

05 - 08

Oct 2026

12 - 13

Oct 2026

Pharmaceutics 2026

Village Hotel Changi, Singapor...

12 - 13

Oct 2026

2nd International Conference on Drug Discovery

Village Hotel Changi, Singapor...

21 - 23

Oct 2026

21 - 22

Oct 2026

22 - 23

Oct 2026

PDA Aseptic Symposium 2026

Congress Square Nakanoshima, O...

26 - 28

Oct 2026

ACHEMA Middle East 2026

RICEC, Riyadh, KSA, Saudi Arab...

26 - 28

Oct 2026

World Orphan Drug Congress

RAI, Amsterdam, Netherlands

LATEST NEWS Read more...

Sensible Biotechnologies Secures $47 Million to Advance Cell-Based mRNA Platform

Sensible Biotechnologies has secured million in financing to advance and scale its platform for producing naturally modified messenger RNA mRNA medicines The funding includes a Series A round

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics

PacBio and TychoBio have entered into a collaboration to generate fulllength RNA data for training artificial intelligence AI models designed to support RNA therapy development for rare diseases

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialise EXPAREL® in the European Union and UK

Pacira BioSciences has entered into a strategic agreement with Molteni Farmaceutici to expand access to EXPAREL bupivacaine liposome injectable suspension for postsurgical pain management across selected European markets

ORIC Pharmaceuticals and Cancer Research UK Partner to Advance CIP2A-Targeted Cancer Therapy

ORIC Pharmaceuticals has entered into an agreement with Cancer Research UK to advance ORIC a potential firstinclass therapy targeting Cancerous Inhibitor of PPA CIPA into clinical development

AstraZeneca Opens New Global R&D Centre in Kendall Square, Cambridge, Massachusetts

AstraZeneca has opened a new global strategic research and development RD centre in Kendall Square Cambridge Massachusetts expanding its presence in the region and strengthening its global research capabilities

Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development

Quotient Sciences and Acesion Pharma have announced a collaboration to use AIenhanced formulation development to support Acesions earlystage pipeline of smallmolecule treatments for atrial fibrillation